Atlas Trials

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Clinical trial NCT01309386 · COMPLETED

Trial details

NCT number
NCT01309386
Sponsor
Janssen Pharmaceutical K.K.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neoplasms
Start date
2010-08-01
Primary completion
2012-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.